Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

GE HealthCare completes the $2.3B Intelerad deal to expand AI-driven imaging, boost recurring revenues and strengthen its cloud-first healthcare platform.

Moby summary of Tenon Medical, Inc.'s Q4 2025 earnings call ...

Tenon Medical, Inc. (NASDAQ:TNON) Q4 2025 Earnings Call Transcript March 19, 2026 Tenon Medical, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.36. Operator: Greetings ...

The Implications For Regulatory And IP Strategy. Legal News and Analysis - USA - Intellectual Property - Conventus Law ...

Thursday, March 19, 2026 at 4:30 p.m. ET Chief Executive Officer — Steven Foster Chief Financial Officer — Kevin Williamson Need a quote from a Motley Fool analyst? Email [email protected] Revenue -- $1.5 ...

Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half ...

The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.

Medical device industry veteran to lead expansion of Saberscope™, the market's first and only single-use video platform for minimally invasive surgery, laparoscopic procedures, and advanced surgical ...

As noted in Chapter 1, the committee was charged by the Food and Drug Administration (FDA) to review the 510(k) clearance process and answer two principal questions: Does the current 510(k) clearance ...

The Millipede88 aspiration catheter. [Image courtesy of Perfuze] Perfuze announced today that it received FDA 510(k) ...